Event Report
-
Public Affairs Committee
Held the "44th Public Relations Seminar
～Message Writing and Speaking Skills to Convey Your Message to the Public -
Secretariat
BioJapan2025 Luncheon Seminar "Meeting the Challenges of Access to Medicines: Co-creation between the Public and Private Sectors
-
Biopharmaceutical Committee
Report on "BioJapan 2025" and participation
About the Opening Ceremony, Keynote Speech and Biopharmaceutical Seminar -
International Affairs Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
~Toward Securing Crisis-Response Medicines and Other Products (MCM) for Infectious Diseases -
Biopharmaceutical Committee
JPMA Media Forum" was held (Part 2)
Two Major Issues in Countermeasures against Infectious Diseases: Consideration of Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Affairs Committee
JPMA Media Forum" was held (Part 1)
Two Major Issues in Countermeasures against Infectious Diseases: Consideration of Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
Public Affairs Committee
The 43rd Public Relations Seminar" was held.
～Message Writing and Speaking Skills to Convey Your Message to the Public -
Secretariat
JPMA President Kinoshita speaks at a panel organized by "Endpoints News" in the U.S.
-
Secretariat
JPMA Executive Director Ishida speaks at online event for students
-
Public Affairs Committee
Held the 36th JPMA Policy Seminar
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Diverse Values of Pharmaceuticals "What are the diverse values brought by new modalities - Case study of SMA (Spinal Muscular Atrophy) -
Pharmaceutical Industrial Policy Committee
Report on the "JPMA Rare Disease Day 2025 Symposium
JPMA and RDD Japan Secretariat co-hosted a symposium -
Pharmaceutical Industrial Policy Committee
JPMA Rare Disease Day 2025 Symposium" was held.
-
Intellectual Property Committee
Held the "2025 Life Science Intellectual Property Forum
Intellectual property work at a turning point - what is required of the people who handle it -
Biopharmaceutical Committee
CMC Strategy Forum Japan 2024" will be held
-
Secretariat
The 23rd JPMA Forum" was held
-
Pharmaceutical Industrial Policy Committee
The 4th Economic Security Seminar" was held.
Latest Trends in Cyber Threats and the Pharmaceutical Industry -
International Affairs Committee
Held a special session at the "11th Nikkei-FT Conference on Infectious Diseases
Establishment of an Infectious Drug Discovery Ecosystem - Toward the Implementation Phase -
Public Affairs Committee
The 42nd Public Relations Seminar was held.
～Public Relations Activities from the Perspective of Patients and Their Families -
Biopharmaceutical Committee
Report on "BioJapan 2024" and its participation
Opening Ceremony and Keynote Speech, Biopharmaceutical Committee Seminar -
International Affairs Committee
JPMA Media Forum" Held
Initiatives for Priority Infectious Diseases (including AMR)
-Introduction of the Revised Government Action Plan for H1N1 Influenza and Future Responses -
Biopharmaceutical Committee
JPMA Media Forum" Held
Life Course Immunization in the Era of 100 Years of Life -
Public Affairs Committee
The 41st Public Relations Seminar
How Public Relations Works in the Age of AI -
Public Affairs Committee
The 35th JPMA Policy Seminar Held
Toward a Nation Driven by Innovation: Strengthening Japan's Drug Discovery Capabilities and Universal Health Coverage -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Considering the various values that pharmaceuticals can bring - For the rich everyday life that patients and their families desire -
Intellectual Property Committee
Held the "2024 Life Science Intellectual Property Forum
Now is the time to strengthen Japan's drug discovery capabilities! ～Toward Building a Robust Drug Discovery Ecosystem for New Modalities -
Pharmaceutical Industrial Policy Committee
JPMA Rare Disease Day 2024 Symposium" was held
-
ICH Project
The 5th ICH Forum: ICH Quality Guideline Update
-
Secretariat
The 22nd JPMA Forum" was held.
-
International Affairs Committee
Joint Conference on Global Health 2023" was held.
Co-sponsored Symposium on "Drug Resistance (AMR) as a Global Health Challenge. -
Public Affairs Committee
The 40th Public Relations Seminar
-Social networking and web literacy seminar -
International Affairs Committee
Special Session Held at the 10th Nikkei-FT Conference on Infectious Diseases
Toward the Creation of a Drug Discovery Ecosystem in the Infectious Disease Field: A Year in Review and Future Initiatives -
Biopharmaceutical Committee
Report on "BioJapan 2023
Opening Ceremony and Keynote Speech, Biopharmaceutical Committee Seminar -
Pharmaceutical Industrial Policy Committee
Seminar on Economic Security and Cyber Security" was held
-
International Affairs Committee
JPMA Aging Group and HGPI Joint Symposium Held
Health Challenges Associated with Aging, Dementia and Cancer - Early Initiatives to Extend Healthy Life Expectancy -
The Office of Pharmaceutical Industry Research
Forum on "The Value of Drugs and DTx for the Public" hosted by the Institute for Policy Studies
-
Public Affairs Committee
The 39th Public Relations Seminar" Held
-What was discussed at the Expert Panel Meeting? -
International Affairs Committee
JPMA Media Forum" Held
Action Plan for Combating Drug Resistance (AMR) 2023-2027 - Key Points and Future Responses -
Pharmaceutical Industrial Policy Committee
Economic Security Seminar "Economic Security and the Pharmaceutical Industry
-
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Health and Economy "The World's Focus: The Future of Health Economics Research in Japan's Aging Society" -
International Affairs Committee
Joint Symposium with the Joint Annual Meeting of the Japanese Society of Infectious Diseases and the Japanese Society of Chemotherapy
Bringing antimicrobials from Japan back to the world! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration -
Biopharmaceutical Committee
JPMA Media Forum" Held
What to do about Vaccines? -What we can do now for the future -
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration? -
Public Affairs Committee
JPMA Media Forum" Held
-The current trend of science, technology and innovation from a bird's eye view of the life science field and its implications for the drug discovery field -
Public Affairs Committee
JPMA Presidents Press Conference
Business Model of the Pharmaceutical Industry and Pharmaceutical Industry Policy and Recommendations 2023 -
Intellectual Property Committee
Held the "2023 Life Science IP Forum
-Current Status, Prospects and Challenges of Digital Therapeutics (DTx) -
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" was held
-
Patient Cooperation Committee
The 40th JPMA Patient Group Seminar" was held.
Thinking Together and Taking Steps Forward, Patient and Public Involvement in Healthcare (PPI) -
Secretariat
The 21st JPMA Forum" was held.
-
International Affairs Committee
JPMA Media Forum" Held
-Antimicrobial Resistance (AMR) Promotion Month -
Public Affairs Committee
The 38th Public Relations Seminar
-ESG Management, Information Disclosure and Relationship with Society -
Biopharmaceutical Committee
Report on the BioJapan 2022
Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Affairs Committee
JPMA President to Speak at Special Session at Nikkei Cross Health EXPO 2022
Directions and Challenges for the Transformation of Pharmaceutical Companies in the Era of Innovation Ecosystems -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Aiming for Appropriate Use of Pharmaceuticals -To Deliver Reliable Drug Information to Patients -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Considering the various values that pharmaceuticals can bring - For the rich everyday life that patients and their families desire -
International Affairs Committee
JPMA Media Forum" Held
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Affairs Committee
The 37th Public Relations Seminar
-News Explanation, News Program Production Today -
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration? -
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
Public Affairs Committee
JPMA Media Forum" Held
Vaccination in the Era of With Corona - Learning from Pandemics -
Secretariat
The 20th JPMA Forum" held
-
Patient Cooperation Committee
The 39th JPMA Patient Group Seminar" was held.
Let's Think Together, Future Drug Development (Clinical Trials) - Let's Open the Door to the Future Together -
International Affairs Committee
Special Program at the 8th Nikkei-FT Conference on Infectious Diseases
Preparing for Emerging and Re-emerging Infectious Diseases including Drug Resistant Bacteria - Unknown Threats, National Response -
Public Affairs Committee
Held the 36th Public Relations Seminar.
From Strategic PR to Narrative Company: New PR and Companies after the New Normal -
Biopharmaceutical Committee
Report on "BioJapan 2021" and its participation
Biopharmaceutical Committee Seminar -
International Affairs Committee
JPMA Media Forum" Held
The need for new antimicrobial agents against Antimicrobial Resistance (AMR) reaffirmed by the new coronavirus pandemic -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Reconsidering the Diverse Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals? -
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Intellectual Property Committee
Held the "2021 Life Science IP Forum
Theme is "How to handle IP rights in pandemic response measures including COVID-19" -
Public Affairs Committee
JPMA Media Forum" Held
What is a Vaccine? -Learning about vaccines once again in the Corona Disaster -
Patient Cooperation Committee
The 38th JPMA Patient Group Seminar" was held.
Online Patient Group Activities - What We Can Do Now -
ICH Project
GCP Renovation Seminar" was held
-
Biopharmaceutical Committee
Report on "BioJapan 2020
Biopharmaceutical Committee Seminar -
International Affairs Committee
JPMA held a lunch session at the 7th Nikkei-FT Conference on Infectious Diseases
Proposal to strengthen future measures against infectious diseases through industry-academia-government collaboration -
Intellectual Property Committee
Held the "2020 Life Science IP Forum
How to protect new businesses that use digital data as a source of value -
Consumer Consultation Review Committee
JPMA Holds Consumer Consultation Review Committee Forum
Considering how information should be provided to patients - Looking ahead to the next generation -
Consumer Consultation Review Committee
JPMA Holds Consumer Consultation Review Committee Forum
Considering how information should be provided to patients - Looking ahead to the next generation -
Public Affairs Committee
JPMA Media Forum" Held
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information
-
Public Affairs Committee
JPMA and AMED "Joint Press Conference
Announcing the launch of AND-E, a new framework for collaboration to strengthen the drug discovery ecosystem -
Public Affairs Committee
JPMA Presidents Press Conference
New President Asuka Miyabashira makes a speech -
Public Affairs Committee
JPMA Presidents Press Conference
JPMA's Vision for 2035 and JPMA's Policy Proposals for 2025 released -
Public Affairs Committee
JPMA Presidents Press Conference
Expectations for the New Administration -
Public Affairs Committee
JPMA Presidents Press Conference
Aiming for a Nation Driven by Innovation -
Public Affairs Committee
JPMA Presidents Press Conference
Hiroaki Ueno, New President, Delivers a Statement of Position -
Public Affairs Committee
JPMA Presidents Press Conference
Current status and recognition of issues surrounding the pharmaceutical industry and basic framework for their solution -
Public Affairs Committee
JPMA Presidents Press Conference
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues -
Public Affairs Committee
JPMA Presidents Press Conference
New President Yasushi Okada Delivers his Message -
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference Held
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Affairs Committee
JPMA Presidents Press Conference
Necessity of Industrial Policy in the JPMA Industry" and "JPMA Policy Proposal 2021 -
Public Affairs Committee
JPMA holds a press conference
Lessons learned from the spread of novel coronavirus infection and preparation for drug resistance (AMR) -
Public Affairs Committee
Held the Chairman's Press Conference.
JPMA Activity Policy for FY2020, JPMA Proposal for the Creation of Infectious Disease Therapeutics and Vaccines, Proposal for the Framework Policy 2020, and JPMA Policy Proposal 2019 in Progress -
Public Affairs Committee
JPMA Presidents Press Conference
JPMA's Initiatives: Progress and Future - Pursuit of Innovation and Resolution of Social Issues
-
Public Affairs Committee
Held the "JPMA Kusurium Laboratory," a hands-on event
Permanent Exhibition Room "Drug Room - Kusurium" also features three new exhibits -
Public Affairs Committee
Educational event on pharmaceutical and medical issues "Living with Disease. Living with Hope. Photo Exhibition" was held.
To the future that creates, answers that have not yet been seen -
Public Affairs Committee
JPMA special program: TV-Iwate "Oraho no Kenko - Protecting Oraho's Health with Pharmaceuticals" (TV-Iwate) Oraho's Health Protected by Pharmaceuticals: Ten Years after the Earthquake and the Need for Countermeasures to Combat Infectious Diseases
*No view of 2021 is included in the program. -
Public Affairs Committee
Medical Information Program "Iroshin Yakushin Yume no Meditemple 2021 Special" is now being broadcast by popular demand!
-
Public Affairs Committee
JPMA special program "Yamaguchi, Yamaguchi" broadcast by KRY Yamaguchi Broadcasting Co! Buchi Genki! ～The 4th Symposium on the Regulation of Medical Products in Japan and India" was held.
-
International Affairs Committee
The Third Annual Neglected Tropical Diseases Contest is Held
-
Pharmaceutical Industrial Policy Committee
The Fifth Seminar on Economic Security
Economic Security and the Pharmaceutical Industry -
Biopharmaceutical Committee
CMC Strategy Forum Japan 2025" was held
-
APAC Project
Visit to three Southeast Asian countries for the 15th Asian Pharmaceutical Association Conference (APAC)
- Mission: Enhancing access to innovative medicines for the people in Asia -
～Enhancing access to innovative medicines for the people in Asia - -
ICH Project
ICH Singapore Meeting" will be held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Report on side events held during the UN Assembly
Global Development of NCDs Control through Innovation and Multi-Stakeholder Partnerships from Japan: Pathways to Realization of UHC -
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for 2025
-
Quality & Technology Committee
The 52nd GMP Case Study Workshop in FY2025
Strengthening Quality Assurance Implementation Capability and Site-Driven Problem Solving Approach -
Regulatory Affairs Committee
The 15th Annual Meeting of the Regulatory Science Society of Japan held
Quality Assurance and Regulatory Science -
International Affairs Committee
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
Secretariat
JPMA holds its first "Co-creation Meeting!
Chairpersons, officers, and secretariat gather to discuss the realization of Industrial Vision 2035 -
International Affairs Committee
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industry from Japan and Korea gathered to discuss common issues -
International Affairs Committee
Strengthening Strategic Partnerships to Combat Infectious Diseases (Vector-borne Diseases, Neglected Tropical Diseases, and Emerging Infectious Diseases)" WHA78 Side Event in Geneva
Japan's Contribution and Strategic Partnerships in the Fight against Infectious Diseases -
Pharmaceutical Industrial Policy Committee
JPMA members participate in the DIA 2025 Global Annual Meeting
Global communication on efforts to tackle the drug lag and loss problem -
APAC Project
The 14th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference Held
Mission: To bring innovative medicines to the people of Asia in a timely manner -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee in 2025
-
International Affairs Committee
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview Management and Practice Managers in 2024" was held
-
Code Compliance Committee
Held the "FY2024 Meeting for Persons Responsible for Compliance Management and Practice Managers
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
International Affairs Committee
The 2nd Neglected Tropical Diseases Contest" was held.
-
Drug Evaluation Committee
Assembly of Drug Evaluation Committee in 2024
Patient and Public Involvement" - For Whom We Work -
ICH Project
ICH Montreal Meeting" will be held
-
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
International Affairs Committee
The 12th Taiwan-Japan Pharmaceutical Exchange Conference
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for 2024
-
Regulatory Affairs Committee
The 14th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science for the Future of Medicine -
APAC Project
The APEC Regulatory Harmonization Steering Committee (APEC RHSC) of the 2024 Asia-Pacific Economic Cooperation Conference was held
-
International Affairs Committee
The 7th Japan-India Symposium on Regulation of Medical Products held in New Delhi
-
ICH Project
ICH Fukuoka Meeting Held in Fukuoka, Japan
-
International Affairs Committee
PMDA and JPMA to Jointly Organize "JAPAN Session" at DIA China 2024
-
Drug Evaluation Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY 2024
-
APAC Project
The 13th Asian Pharmaceutical Association Conference (APAC) held
-Mission: To rapidly deliver innovative medicines to the people of Asia -
Pharmaceutical Industrial Policy Committee
Briefing on the Revision of the Cost-Effectiveness Evaluation System in Fiscal 2024
-
Code Compliance Committee
Meeting of Compliance Managers and Practitioners for FY2023
-
International Affairs Committee
The First Neglected Tropical Diseases Student Contest and Online Event on World NTD Day 2024
-
International Affairs Committee
The 10th Japan-Thailand Joint Symposium" was held.
-
International Affairs Committee
The 4th Japan-Vietnam Joint Symposium" will be held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2023" will be held
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY 2023
Breakthrough to Drug Loss - Aiming to Realize Safe, Secure, and Well-Being Medicine and Society -
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Prague Meeting" was held
-
Drug Evaluation Committee
Workshop on "Next Generation Adverse Reaction Case Evaluation" was held.
-
Review Board of Ethical Drug Product Information Brochure
Briefing on the Revision of the "Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs" Held
-
International Affairs Committee
The 11th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
-
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2023
-
Regulatory Affairs Committee
The 13th Annual Conference of the Regulatory Science Society of Japan" was held
Progress and Harmonization Required in Regulatory Science -
Quality & Technology Committee
The 50th GMP Case Study Workshop in FY 2023 (the 50th)" was held
-
APAC Project
APEC Good Registration Management (GRM),Center of Excellence (CoE) Workshop 2023" was held.
First local workshop held after the COVID-19 pandemic -
International Affairs Committee
The 5th Japan-Korea Symposium on Regulation of Medical Products
-
International Affairs Committee
Opinion Exchange Meeting with Mr. Dao Hong Lan, Minister of Health of Vietnam" was held.
-
ICH Project
ICH Vancouver Meeting" was held
-
Consumer Consultation Review Committee
Assembly of the Consumer Consultation Review Committee for FY2023
-
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY2023
-
APAC Project
The 12th Asian Pharmaceutical Association Collaboration Conference (APAC)
-Delivering Innovative Medicines to the People of Asia Promptly -
Code Compliance Committee
Meeting of Compliance Managers and Practitioners for Fiscal Year 2022
-
International Affairs Committee
The 6th Japan-India Symposium on Regulation of Medical Products
-
International Affairs Committee
The 9th Japan-Thailand Joint Symposium" will be held
-
International Affairs Committee
The 3rd Japan-Vietnam Joint Symposium" was held
-
APAC Project
The 1st APAC e-labeling Regulators Workshop" was held.
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY2022
Paving the way to the future of healthcare through Digital Transformation! ～From Disease to Pre-disease and Well being -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
International Affairs Committee
Special Session at the 9th Nikkei-FT Infectious Diseases Conference
Toward the Creation of a Drug Discovery Ecosystem in the Field of Infectious Diseases - Focusing on Collaboration among Industry, Government, and Academia -
ICH Project
ICH Incheon Meeting" was held
-
The Office of Pharmaceutical Industry Research
The Economics of Invention," a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Award.
-
International Affairs Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference" was held
-
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2022
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan" was held
Current status and future of human resource development for regulatory science -
International Affairs Committee
The 2nd Japan-Malaysia Symposium" will be held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Athens Meeting Held in Hybrid Format for the First Time
-
Drug Evaluation Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY 2022
-
APAC Project
The 11th APAC (Asian Pharmaceutical Association Collaboration Conference)
-Mission: Bringing Innovative Medicines to the People of Asia Promptly
Theme: "APAC: Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview Management and Practice Management in FY2021" was held.
-
Pharmaceutical Industrial Policy Committee
Information Meeting on "Cost-Effectiveness Evaluation System
-
ICH Project
Report on "Briefing Session on eCTD v4.0 (ICH M8) Notification Revision and Start of Implementation
-
Code Compliance Committee
2021 Meeting of Compliance Managers and Practitioners in Charge of Compliance Management
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The 8th Japan-Thailand Joint Symposium" was held
-
International Affairs Committee
The 5th Japan-India Symposium on Regulation of Medical Products
Proactive Communication for the Development of Japan-India Cooperation Scheme in the Pharmaceutical Field -
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2021" will be held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Vancouver Meeting to be Held via Web Conference
-
Drug Evaluation Committee
The 139th Assembly of the Drug Evaluation Committee
Looking Back on the New Coronavirus - Sharing Best Practices and Resolving Domestic Issues -
The Office of Pharmaceutical Industry Research
Workshop on the Value of Drugs: Considering the Value of Drugs and Their Evaluation from the Perspective of the Public and Patients," hosted by the Policy Research Institute
-
International Affairs Committee
The 9th Taiwan-Japan Pharmaceutical Exchange Conference" was held.
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (LEEM)
-
Pharmaceutical Industrial Policy Committee
Holding of "Pharmaceutical Industry Vision 2021 Briefing Session
-
Code Compliance Committee
The "2021 Meeting of Code Administration Managers and Practitioners" was held
-
Regulatory Affairs Committee
The 11th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to accelerate social implementation -
Pharmaceutical Industrial Policy Committee
Guideline Workshops on the Revised Tax Credit System for Special Research Expenses" held
-
Quality & Technology Committee
The 48th GMP Case Study Workshop in FY2021
-
ICH Project, International Affairs Committee
Japan-China ICH Joint Symposium" Held
-
ICH Project
ICH Incheon Conference to be Held via Web Conference
-
International Affairs Committee
PMDA and JPMA Jointly Host COVID-19 Session at DIA China 2021
-
International Affairs Committee
The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
-
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for 2021" was held
-
APAC Project
Held the 10th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference
-Mission: Delivering Innovative Medicines to the People of Asia Quickly
The theme is "Overcoming COVID-19 and Toward a Decade of New Innovation Challenges in Asia -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview and Management and for Practical Responsibility in FY2020" was held.
-
Code Compliance Committee
Held the "FY2020 Meeting of Compliance Managers and Managers in Charge of Compliance Management
-
International Affairs Committee
Exchange of views with the International Atomic Energy Agency (IAEA) and the Permanent Mission of Japan to the International Organizations in Vienna on various issues in the health sector
-
International Affairs Committee
The 7th Japan-Thailand Joint Symposium" was held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2020" held
-
International Affairs Committee
The 2nd Japan-Vietnam Joint Symposium" was held
-
Drug Evaluation Committee
Joint Assembly of the Drug Evaluation Committee and Regulatory Affairs Committee for FY2020" was held.
-
International Affairs Committee
The 8th Taiwan-Japan Pharmaceutical Conference to be held
-
Code Compliance Committee
FY2020 Meeting of Code Administration Managers and Practitioners
-
Regulatory Affairs Committee
The 10th Annual Meeting of the Regulatory Science Society of Japan held
-
Quality & Technology Committee
The "FY2020 (47th) GMP Case Study Workshop
-
ICH Project
ICH M8 eCTD v4.0 Revision Notification Briefing
Briefing Session on eCTD v4.0 Implementation in Japan -
ICH Project
ICH Vancouver Conference" held in the form of a web conference
-
Quality & Technology Committee
The 22nd Pharmaceutical Quality Forum Symposium" held
Current status of the ICH-Q series -
Regulatory Affairs Committee
The 8th Regulatory Affairs Committee Symposium" held
Consider what can be done to make face-to-face advice and review more efficient -
International Affairs Committee
The 4th Japan-India Symposium on Regulation of Medical Products
Maturation of discussions on pharmaceutical regulations between Japan and India (Japan-India) and further development into an international cooperation scheme
-
International Affairs Committee
The Third Annual Neglected Tropical Diseases Contest is Held
-
Public Affairs Committee
JPMA and AMED "Joint Press Conference
Announcing the launch of AND-E, a new framework for collaboration to strengthen the drug discovery ecosystem -
Pharmaceutical Industrial Policy Committee
The Fifth Seminar on Economic Security
Economic Security and the Pharmaceutical Industry -
Biopharmaceutical Committee
CMC Strategy Forum Japan 2025" was held
-
APAC Project
Visit to three Southeast Asian countries for the 15th Asian Pharmaceutical Association Conference (APAC)
- Mission: Enhancing access to innovative medicines for the people in Asia -
～Enhancing access to innovative medicines for the people in Asia - -
Public Affairs Committee
Held the "44th Public Relations Seminar
～Message Writing and Speaking Skills to Convey Your Message to the Public -
ICH Project
ICH Singapore Meeting" will be held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
Secretariat
BioJapan2025 Luncheon Seminar "Meeting the Challenges of Access to Medicines: Co-creation between the Public and Private Sectors
-
Biopharmaceutical Committee
Report on "BioJapan 2025" and participation
About the Opening Ceremony, Keynote Speech and Biopharmaceutical Seminar -
International Affairs Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
~Toward Securing Crisis-Response Medicines and Other Products (MCM) for Infectious Diseases -
International Affairs Committee
Report on side events held during the UN Assembly
Global Development of NCDs Control through Innovation and Multi-Stakeholder Partnerships from Japan: Pathways to Realization of UHC -
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for 2025
-
Quality & Technology Committee
The 52nd GMP Case Study Workshop in FY2025
Strengthening Quality Assurance Implementation Capability and Site-Driven Problem Solving Approach -
Regulatory Affairs Committee
The 15th Annual Meeting of the Regulatory Science Society of Japan held
Quality Assurance and Regulatory Science -
Biopharmaceutical Committee
JPMA Media Forum" was held (Part 2)
Two Major Issues in Countermeasures against Infectious Diseases: Consideration of Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Affairs Committee
JPMA Media Forum" was held (Part 1)
Two Major Issues in Countermeasures against Infectious Diseases: Consideration of Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Affairs Committee
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
Secretariat
JPMA holds its first "Co-creation Meeting!
Chairpersons, officers, and secretariat gather to discuss the realization of Industrial Vision 2035 -
International Affairs Committee
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industry from Japan and Korea gathered to discuss common issues -
International Affairs Committee
Strengthening Strategic Partnerships to Combat Infectious Diseases (Vector-borne Diseases, Neglected Tropical Diseases, and Emerging Infectious Diseases)" WHA78 Side Event in Geneva
Japan's Contribution and Strategic Partnerships in the Fight against Infectious Diseases -
Pharmaceutical Industrial Policy Committee
JPMA members participate in the DIA 2025 Global Annual Meeting
Global communication on efforts to tackle the drug lag and loss problem -
Public Affairs Committee
The 43rd Public Relations Seminar" was held.
～Message Writing and Speaking Skills to Convey Your Message to the Public -
Public Affairs Committee
JPMA Presidents Press Conference
New President Asuka Miyabashira makes a speech -
Secretariat
JPMA President Kinoshita speaks at a panel organized by "Endpoints News" in the U.S.
-
Secretariat
JPMA Executive Director Ishida speaks at online event for students
-
APAC Project
The 14th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference Held
Mission: To bring innovative medicines to the people of Asia in a timely manner -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee in 2025
-
International Affairs Committee
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview Management and Practice Managers in 2024" was held
-
Public Affairs Committee
Held the "JPMA Kusurium Laboratory," a hands-on event
Permanent Exhibition Room "Drug Room - Kusurium" also features three new exhibits -
Code Compliance Committee
Held the "FY2024 Meeting for Persons Responsible for Compliance Management and Practice Managers
-
Public Affairs Committee
Held the 36th JPMA Policy Seminar
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society -
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Diverse Values of Pharmaceuticals "What are the diverse values brought by new modalities - Case study of SMA (Spinal Muscular Atrophy) -
Public Affairs Committee
JPMA Presidents Press Conference
JPMA's Vision for 2035 and JPMA's Policy Proposals for 2025 released -
Pharmaceutical Industrial Policy Committee
Report on the "JPMA Rare Disease Day 2025 Symposium
JPMA and RDD Japan Secretariat co-hosted a symposium -
Pharmaceutical Industrial Policy Committee
JPMA Rare Disease Day 2025 Symposium" was held.
-
Intellectual Property Committee
Held the "2025 Life Science Intellectual Property Forum
Intellectual property work at a turning point - what is required of the people who handle it -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
International Affairs Committee
The 2nd Neglected Tropical Diseases Contest" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2024" will be held
-
Secretariat
The 23rd JPMA Forum" was held
-
Pharmaceutical Industrial Policy Committee
The 4th Economic Security Seminar" was held.
Latest Trends in Cyber Threats and the Pharmaceutical Industry -
Drug Evaluation Committee
Assembly of Drug Evaluation Committee in 2024
Patient and Public Involvement" - For Whom We Work -
ICH Project
ICH Montreal Meeting" will be held
-
International Affairs Committee
Held a special session at the "11th Nikkei-FT Conference on Infectious Diseases
Establishment of an Infectious Drug Discovery Ecosystem - Toward the Implementation Phase -
Public Affairs Committee
The 42nd Public Relations Seminar was held.
～Public Relations Activities from the Perspective of Patients and Their Families -
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
Biopharmaceutical Committee
Report on "BioJapan 2024" and its participation
Opening Ceremony and Keynote Speech, Biopharmaceutical Committee Seminar -
Public Affairs Committee
JPMA Presidents Press Conference
Expectations for the New Administration -
International Affairs Committee
The 12th Taiwan-Japan Pharmaceutical Exchange Conference
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
JPMA Media Forum" Held
Initiatives for Priority Infectious Diseases (including AMR)
-Introduction of the Revised Government Action Plan for H1N1 Influenza and Future Responses -
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for 2024
-
Regulatory Affairs Committee
The 14th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science for the Future of Medicine -
Biopharmaceutical Committee
JPMA Media Forum" Held
Life Course Immunization in the Era of 100 Years of Life -
APAC Project
The APEC Regulatory Harmonization Steering Committee (APEC RHSC) of the 2024 Asia-Pacific Economic Cooperation Conference was held
-
International Affairs Committee
The 7th Japan-India Symposium on Regulation of Medical Products held in New Delhi
-
ICH Project
ICH Fukuoka Meeting Held in Fukuoka, Japan
-
Public Affairs Committee
The 41st Public Relations Seminar
How Public Relations Works in the Age of AI -
International Affairs Committee
PMDA and JPMA to Jointly Organize "JAPAN Session" at DIA China 2024
-
Drug Evaluation Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY 2024
-
APAC Project
The 13th Asian Pharmaceutical Association Conference (APAC) held
-Mission: To rapidly deliver innovative medicines to the people of Asia -
Pharmaceutical Industrial Policy Committee
Briefing on the Revision of the Cost-Effectiveness Evaluation System in Fiscal 2024
-
Public Affairs Committee
Educational event on pharmaceutical and medical issues "Living with Disease. Living with Hope. Photo Exhibition" was held.
To the future that creates, answers that have not yet been seen -
Code Compliance Committee
Meeting of Compliance Managers and Practitioners for FY2023
-
Public Affairs Committee
The 35th JPMA Policy Seminar Held
Toward a Nation Driven by Innovation: Strengthening Japan's Drug Discovery Capabilities and Universal Health Coverage -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Considering the various values that pharmaceuticals can bring - For the rich everyday life that patients and their families desire -
Public Affairs Committee
JPMA Presidents Press Conference
Aiming for a Nation Driven by Innovation -
Intellectual Property Committee
Held the "2024 Life Science Intellectual Property Forum
Now is the time to strengthen Japan's drug discovery capabilities! ～Toward Building a Robust Drug Discovery Ecosystem for New Modalities -
Pharmaceutical Industrial Policy Committee
JPMA Rare Disease Day 2024 Symposium" was held
-
International Affairs Committee
The First Neglected Tropical Diseases Student Contest and Online Event on World NTD Day 2024
-
International Affairs Committee
The 10th Japan-Thailand Joint Symposium" was held.
-
ICH Project
The 5th ICH Forum: ICH Quality Guideline Update
-
International Affairs Committee
The 4th Japan-Vietnam Joint Symposium" will be held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2023" will be held
-
Secretariat
The 22nd JPMA Forum" was held.
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY 2023
Breakthrough to Drug Loss - Aiming to Realize Safe, Secure, and Well-Being Medicine and Society -
International Affairs Committee
Joint Conference on Global Health 2023" was held.
Co-sponsored Symposium on "Drug Resistance (AMR) as a Global Health Challenge. -
Public Affairs Committee
The 40th Public Relations Seminar
-Social networking and web literacy seminar -
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Prague Meeting" was held
-
Drug Evaluation Committee
Workshop on "Next Generation Adverse Reaction Case Evaluation" was held.
-
International Affairs Committee
Special Session Held at the 10th Nikkei-FT Conference on Infectious Diseases
Toward the Creation of a Drug Discovery Ecosystem in the Infectious Disease Field: A Year in Review and Future Initiatives -
Review Board of Ethical Drug Product Information Brochure
Briefing on the Revision of the "Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs" Held
-
Biopharmaceutical Committee
Report on "BioJapan 2023
Opening Ceremony and Keynote Speech, Biopharmaceutical Committee Seminar -
International Affairs Committee
The 11th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
-
Pharmaceutical Industrial Policy Committee
Seminar on Economic Security and Cyber Security" was held
-
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2023
-
International Affairs Committee
JPMA Aging Group and HGPI Joint Symposium Held
Health Challenges Associated with Aging, Dementia and Cancer - Early Initiatives to Extend Healthy Life Expectancy -
Regulatory Affairs Committee
The 13th Annual Conference of the Regulatory Science Society of Japan" was held
Progress and Harmonization Required in Regulatory Science -
Quality & Technology Committee
The 50th GMP Case Study Workshop in FY 2023 (the 50th)" was held
-
APAC Project
APEC Good Registration Management (GRM),Center of Excellence (CoE) Workshop 2023" was held.
First local workshop held after the COVID-19 pandemic -
International Affairs Committee
The 5th Japan-Korea Symposium on Regulation of Medical Products
-
The Office of Pharmaceutical Industry Research
Forum on "The Value of Drugs and DTx for the Public" hosted by the Institute for Policy Studies
-
Public Affairs Committee
The 39th Public Relations Seminar" Held
-What was discussed at the Expert Panel Meeting? -
International Affairs Committee
Opinion Exchange Meeting with Mr. Dao Hong Lan, Minister of Health of Vietnam" was held.
-
International Affairs Committee
JPMA Media Forum" Held
Action Plan for Combating Drug Resistance (AMR) 2023-2027 - Key Points and Future Responses -
Pharmaceutical Industrial Policy Committee
Economic Security Seminar "Economic Security and the Pharmaceutical Industry
-
ICH Project
ICH Vancouver Meeting" was held
-
Public Affairs Committee
JPMA Presidents Press Conference
Hiroaki Ueno, New President, Delivers a Statement of Position -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Health and Economy "The World's Focus: The Future of Health Economics Research in Japan's Aging Society" -
Consumer Consultation Review Committee
Assembly of the Consumer Consultation Review Committee for FY2023
-
International Affairs Committee
Joint Symposium with the Joint Annual Meeting of the Japanese Society of Infectious Diseases and the Japanese Society of Chemotherapy
Bringing antimicrobials from Japan back to the world! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY2023
-
APAC Project
The 12th Asian Pharmaceutical Association Collaboration Conference (APAC)
-Delivering Innovative Medicines to the People of Asia Promptly -
Biopharmaceutical Committee
JPMA Media Forum" Held
What to do about Vaccines? -What we can do now for the future -
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration? -
Code Compliance Committee
Meeting of Compliance Managers and Practitioners for Fiscal Year 2022
-
Public Affairs Committee
JPMA Media Forum" Held
-The current trend of science, technology and innovation from a bird's eye view of the life science field and its implications for the drug discovery field -
Public Affairs Committee
JPMA Presidents Press Conference
Business Model of the Pharmaceutical Industry and Pharmaceutical Industry Policy and Recommendations 2023 -
Intellectual Property Committee
Held the "2023 Life Science IP Forum
-Current Status, Prospects and Challenges of Digital Therapeutics (DTx) -
International Affairs Committee
The 6th Japan-India Symposium on Regulation of Medical Products
-
International Affairs Committee
The 9th Japan-Thailand Joint Symposium" will be held
-
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" was held
-
Patient Cooperation Committee
The 40th JPMA Patient Group Seminar" was held.
Thinking Together and Taking Steps Forward, Patient and Public Involvement in Healthcare (PPI) -
International Affairs Committee
The 3rd Japan-Vietnam Joint Symposium" was held
-
APAC Project
The 1st APAC e-labeling Regulators Workshop" was held.
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY2022
Paving the way to the future of healthcare through Digital Transformation! ～From Disease to Pre-disease and Well being -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
Secretariat
The 21st JPMA Forum" was held.
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
International Affairs Committee
Special Session at the 9th Nikkei-FT Infectious Diseases Conference
Toward the Creation of a Drug Discovery Ecosystem in the Field of Infectious Diseases - Focusing on Collaboration among Industry, Government, and Academia -
ICH Project
ICH Incheon Meeting" was held
-
International Affairs Committee
JPMA Media Forum" Held
-Antimicrobial Resistance (AMR) Promotion Month -
The Office of Pharmaceutical Industry Research
The Economics of Invention," a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Award.
-
International Affairs Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference" was held
-
Public Affairs Committee
The 38th Public Relations Seminar
-ESG Management, Information Disclosure and Relationship with Society -
Biopharmaceutical Committee
Report on the BioJapan 2022
Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Affairs Committee
JPMA President to Speak at Special Session at Nikkei Cross Health EXPO 2022
Directions and Challenges for the Transformation of Pharmaceutical Companies in the Era of Innovation Ecosystems -
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2022
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan" was held
Current status and future of human resource development for regulatory science -
Public Affairs Committee
JPMA Presidents Press Conference
Current status and recognition of issues surrounding the pharmaceutical industry and basic framework for their solution -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Aiming for Appropriate Use of Pharmaceuticals -To Deliver Reliable Drug Information to Patients -
International Affairs Committee
The 2nd Japan-Malaysia Symposium" will be held
-
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Considering the various values that pharmaceuticals can bring - For the rich everyday life that patients and their families desire -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Athens Meeting Held in Hybrid Format for the First Time
-
Drug Evaluation Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY 2022
-
International Affairs Committee
JPMA Media Forum" Held
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Affairs Committee
The 37th Public Relations Seminar
-News Explanation, News Program Production Today -
APAC Project
The 11th APAC (Asian Pharmaceutical Association Collaboration Conference)
-Mission: Bringing Innovative Medicines to the People of Asia Promptly
Theme: "APAC: Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview Management and Practice Management in FY2021" was held.
-
Pharmaceutical Industrial Policy Committee
Information Meeting on "Cost-Effectiveness Evaluation System
-
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration? -
ICH Project
Report on "Briefing Session on eCTD v4.0 (ICH M8) Notification Revision and Start of Implementation
-
Code Compliance Committee
2021 Meeting of Compliance Managers and Practitioners in Charge of Compliance Management
-
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The 8th Japan-Thailand Joint Symposium" was held
-
Public Affairs Committee
JPMA Presidents Press Conference
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues -
Public Affairs Committee
JPMA Media Forum" Held
Vaccination in the Era of With Corona - Learning from Pandemics -
International Affairs Committee
The 5th Japan-India Symposium on Regulation of Medical Products
Proactive Communication for the Development of Japan-India Cooperation Scheme in the Pharmaceutical Field -
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2021" will be held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
Secretariat
The 20th JPMA Forum" held
-
Patient Cooperation Committee
The 39th JPMA Patient Group Seminar" was held.
Let's Think Together, Future Drug Development (Clinical Trials) - Let's Open the Door to the Future Together -
ICH Project
ICH Vancouver Meeting to be Held via Web Conference
-
Drug Evaluation Committee
The 139th Assembly of the Drug Evaluation Committee
Looking Back on the New Coronavirus - Sharing Best Practices and Resolving Domestic Issues -
International Affairs Committee
Special Program at the 8th Nikkei-FT Conference on Infectious Diseases
Preparing for Emerging and Re-emerging Infectious Diseases including Drug Resistant Bacteria - Unknown Threats, National Response -
The Office of Pharmaceutical Industry Research
Workshop on the Value of Drugs: Considering the Value of Drugs and Their Evaluation from the Perspective of the Public and Patients," hosted by the Policy Research Institute
-
Public Affairs Committee
Held the 36th Public Relations Seminar.
From Strategic PR to Narrative Company: New PR and Companies after the New Normal -
International Affairs Committee
The 9th Taiwan-Japan Pharmaceutical Exchange Conference" was held.
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (LEEM)
-
Biopharmaceutical Committee
Report on "BioJapan 2021" and its participation
Biopharmaceutical Committee Seminar -
Pharmaceutical Industrial Policy Committee
Holding of "Pharmaceutical Industry Vision 2021 Briefing Session
-
Code Compliance Committee
The "2021 Meeting of Code Administration Managers and Practitioners" was held
-
Regulatory Affairs Committee
The 11th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to accelerate social implementation -
Pharmaceutical Industrial Policy Committee
Guideline Workshops on the Revised Tax Credit System for Special Research Expenses" held
-
Quality & Technology Committee
The 48th GMP Case Study Workshop in FY2021
-
ICH Project, International Affairs Committee
Japan-China ICH Joint Symposium" Held
-
ICH Project
ICH Incheon Conference to be Held via Web Conference
-
International Affairs Committee
PMDA and JPMA Jointly Host COVID-19 Session at DIA China 2021
-
Public Affairs Committee
JPMA Presidents Press Conference
New President Yasushi Okada Delivers his Message -
International Affairs Committee
The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
-
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference Held
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
International Affairs Committee
JPMA Media Forum" Held
The need for new antimicrobial agents against Antimicrobial Resistance (AMR) reaffirmed by the new coronavirus pandemic -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for 2021" was held
-
APAC Project
Held the 10th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference
-Mission: Delivering Innovative Medicines to the People of Asia Quickly
The theme is "Overcoming COVID-19 and Toward a Decade of New Innovation Challenges in Asia -
Public Affairs Committee
JPMA Presidents Press Conference
Necessity of Industrial Policy in the JPMA Industry" and "JPMA Policy Proposal 2021 -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Reconsidering the Diverse Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals? -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview and Management and for Practical Responsibility in FY2020" was held.
-
Code Compliance Committee
Held the "FY2020 Meeting of Compliance Managers and Managers in Charge of Compliance Management
-
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Intellectual Property Committee
Held the "2021 Life Science IP Forum
Theme is "How to handle IP rights in pandemic response measures including COVID-19" -
Public Affairs Committee
JPMA Media Forum" Held
What is a Vaccine? -Learning about vaccines once again in the Corona Disaster -
Public Affairs Committee
JPMA special program: TV-Iwate "Oraho no Kenko - Protecting Oraho's Health with Pharmaceuticals" (TV-Iwate) Oraho's Health Protected by Pharmaceuticals: Ten Years after the Earthquake and the Need for Countermeasures to Combat Infectious Diseases
*No view of 2021 is included in the program. -
International Affairs Committee
Exchange of views with the International Atomic Energy Agency (IAEA) and the Permanent Mission of Japan to the International Organizations in Vienna on various issues in the health sector
-
International Affairs Committee
The 7th Japan-Thailand Joint Symposium" was held
-
Public Affairs Committee
Medical Information Program "Iroshin Yakushin Yume no Meditemple 2021 Special" is now being broadcast by popular demand!
-
Patient Cooperation Committee
The 38th JPMA Patient Group Seminar" was held.
Online Patient Group Activities - What We Can Do Now -
ICH Project
GCP Renovation Seminar" was held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2020" held
-
International Affairs Committee
The 2nd Japan-Vietnam Joint Symposium" was held
-
Drug Evaluation Committee
Joint Assembly of the Drug Evaluation Committee and Regulatory Affairs Committee for FY2020" was held.
-
International Affairs Committee
The 8th Taiwan-Japan Pharmaceutical Conference to be held
-
Biopharmaceutical Committee
Report on "BioJapan 2020
Biopharmaceutical Committee Seminar -
Code Compliance Committee
FY2020 Meeting of Code Administration Managers and Practitioners
-
Regulatory Affairs Committee
The 10th Annual Meeting of the Regulatory Science Society of Japan held
-
Quality & Technology Committee
The "FY2020 (47th) GMP Case Study Workshop
-
Public Affairs Committee
JPMA holds a press conference
Lessons learned from the spread of novel coronavirus infection and preparation for drug resistance (AMR) -
Public Affairs Committee
Held the Chairman's Press Conference.
JPMA Activity Policy for FY2020, JPMA Proposal for the Creation of Infectious Disease Therapeutics and Vaccines, Proposal for the Framework Policy 2020, and JPMA Policy Proposal 2019 in Progress -
International Affairs Committee
JPMA held a lunch session at the 7th Nikkei-FT Conference on Infectious Diseases
Proposal to strengthen future measures against infectious diseases through industry-academia-government collaboration -
ICH Project
ICH M8 eCTD v4.0 Revision Notification Briefing
Briefing Session on eCTD v4.0 Implementation in Japan -
ICH Project
ICH Vancouver Conference" held in the form of a web conference
-
Quality & Technology Committee
The 22nd Pharmaceutical Quality Forum Symposium" held
Current status of the ICH-Q series -
Regulatory Affairs Committee
The 8th Regulatory Affairs Committee Symposium" held
Consider what can be done to make face-to-face advice and review more efficient -
Intellectual Property Committee
Held the "2020 Life Science IP Forum
How to protect new businesses that use digital data as a source of value -
Consumer Consultation Review Committee
JPMA Holds Consumer Consultation Review Committee Forum
Considering how information should be provided to patients - Looking ahead to the next generation -
Consumer Consultation Review Committee
JPMA Holds Consumer Consultation Review Committee Forum
Considering how information should be provided to patients - Looking ahead to the next generation -
International Affairs Committee
The 4th Japan-India Symposium on Regulation of Medical Products
Maturation of discussions on pharmaceutical regulations between Japan and India (Japan-India) and further development into an international cooperation scheme -
Public Affairs Committee
JPMA Media Forum" Held
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information -
Public Affairs Committee
JPMA special program "Yamaguchi, Yamaguchi" broadcast by KRY Yamaguchi Broadcasting Co! Buchi Genki! ～The 4th Symposium on the Regulation of Medical Products in Japan and India" was held.
-
Public Affairs Committee
JPMA Presidents Press Conference
JPMA's Initiatives: Progress and Future - Pursuit of Innovation and Resolution of Social Issues